REPAGLINIDE 1 MG TABLET

Repaglinide
$0.0811per EA

Strength

1 mg/1

NDC

33342024911

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

REPAGLINIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207209

On Market Since

3/22/2023

Pharmacological Classes

Glinide
Potassium Channel Antagonists

Price History

1W

0.0%

1M

+1.3%

3M

-2.9%

6M

-19.3%

1Y

-33.6%

3Y

N/A

5Y

N/A

All

-31.5%